Epidermal growth factor variations in amniotic membrane used for ex vivo tissue constructs

Tissue Engineering - Part A

Volumn 15, Issue 8, 2009, Pages 1919-1927

  Gicquel, Jean Jacques ^a,b   Dua, Harminder S ^a   Brodie, Andrew ^a   Mohammed, Imran ^a   Suleman, Hanif ^a   Lazutina, Elena ^a   James, David K ^c   Hopkinson, Andrew ^a  

^a Nottingham   (United Kingdom)

^b POITIERS UNIVERSITY HOSPITAL   (France)

^c QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOACTIVITY; CELL MEMBRANES; GENE EXPRESSION; PEPTIDES; TISSUE ENGINEERING;

AMNIOTIC MEMBRANES; CLINICAL EFFICACY; CORNEAL EPITHELIAL CELLS; EPIDERMAL GROWTH FACTORS; EPITHELIAL CELLS; EX VIVO EXPANSION; EX-VIVO; PROTEIN CONCENTRATIONS; PROTEIN CONTENTS; PROTEIN EXPRESSIONS; PROTEIN LOSS; REAL-TIME POLYMERASE CHAIN REACTION; TISSUE CONSTRUCTS;

AMPLITUDE MODULATION;

EPIDERMAL GROWTH FACTOR; THERMOLYSIN;

AMNION; ARTICLE; CELL EXPANSION; CONTROLLED STUDY; CORNEA EPITHELIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; ORGAN DONOR; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SCANNING ELECTRON MICROSCOPY; STATISTICAL ANALYSIS; THICKNESS; TISSUE ENGINEERING; TISSUE PRESERVATION;

AMNION; BASEMENT MEMBRANE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIDERMAL GROWTH FACTOR; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; RNA, MESSENGER; SPECIMEN HANDLING; THERMOLYSIN; TISSUE ENGINEERING;

EID: 68749093979     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2008.0432     Document Type: Article

References (57)

1. Dua, H.S., Gomes, J.A., King, A.J., and Maharajan, V.S. The amniotic membrane in ophthalmology. Surv Ophthalmol 49, 51, 2004.
2. Muqit, M.M., Effingham, R.B., and Daniel, C. Technique of amniotic membrane transplant dressing in the management of acute Stevens-Johnson syndrome. Br J Ophthalmol 91, 1536, 2007.
3. Nubile, M., Dua, H.S., Lanzini, T.E., Carpineto, P., Cianca-glini, M., Toto, L., and Mastropasqua, L. Amniotic membrane transplantation for the management of corneal epithelial defects: an in vivo confocal microscopic study. Br J Ophthalmol 92, 54, 2008.
4. Lavery, J.P., Miller, C.E., and Johns, P. Effect of meconium on the strength of chorioamniotic membranes. Obstet Gynecol 56, 711, 1980.
5. Kubo, M., Sonoda, Y., Muramatsu, R., and Usui, M. Im-munogenicity of human amniotic membrane in experimental xenotransplantation. Invest Ophthalmol Vis Sci 42, 1539, 2001.
6. Koizumi, N.J., Inatomi, T.J., Sotozono, C.J., Fullwood, N.J., Quantock, A.J., and Kinoshita, S. Growth factor mRNA and protein in preserved human amniotic membrane. Curr Eye Res 20, 173, 2000.
7. Hao, Y., Ma, D.H., Hwang, D.G., Kim, W.S., and Zhang, F. Identification of antiangiogenic and antiinflammatory proteins in human amniotic membrane. Cornea 19, 348, 2000.
8. Tsai, R.J., Li, L.M., and Chen, J.K. Reconstruction of damaged corneas by transplantation of autologous limbal epithelial cells. N Engl J Med 343, 86, 2000.
9. Koizumi, N., Fullwood, N.J., Bairaktaris, G., Inatomi, T., Kinoshita, S., and Quantock, A.J. Cultivation of corneal epithelial cells on intact and denuded human amniotic membrane. Invest Ophthalmol Vis Sci 41, 2506, 2000.
10. Grueterich, M., Espana, E., and Tseng, S.C. Connexin 43 expression and proliferation of human limbal epithelium on intact and denuded amniotic membrane. Invest Ophthalmol Vis Sci 43, 63, 2002.
11. Grueterich, M., and Tseng, S.C. Human limbal progenitor cells expanded on intact amniotic membrane ex vivo. Arch Ophthalmol 120, 783, 2002.
12. Koizumi, N., Rigby, H., Fullwood, N.J., Kawasaki, S., Tanioka, H., Koizumi, K., Kociok, N., Joussen, A.M., and Kinoshita, S. Comparison of intact and denuded amniotic membrane as a substrate for cell-suspension culture of human limbal epithelial cells. Graefes Arch Clin Exp Ophthalmol 245, 123, 2007.
13. Burman, S., Tejwani, S., Vemuganti, G.K., Gopinathan, U., and Sangwan, V.S. Ophthalmic applications of preserved human amniotic membrane: a review of current indications. Cell Tissue Bank 5, 161, 2004.
14. Hopkinson, A., Shanmuganathan, V.A., Gray, T., Yeung, A.M., Lowe, J., James, D.K., and Dua, H. Optimisation of amniotic membrane denuding for tissue engineering. Tissue Eng Part C Methods 14, 371, 2008.
15. Kurpakus, M.A., Stock, E.L., and Jones, J.C. The role of the basement membrane in differential expression of keratin proteins in epithelial cells. Dev Biol 150, 243, 1992.
16. Streuli, C.H., Bailey, N., and Bissell, M.J. Control of mammary epithelial differentiation: basement membrane induces tissue-specific gene expression in the absence of cell-cell interaction and morphological polarity. J Cell Biol 115, 1383, 1991.
17. Grueterich, M., Espana, E.M., and Tseng, S.C. Ex vivo expansion of limbal epithelial stem cells: amniotic membrane serving as a stem cell niche. Surv Ophthalmol 48, 631, 2003.
18. Andriani, F., Margulis, A., Lin, N., Griffey, S., and Garlick, J.A. Analysis of microenvironmental factors contributing to basement membrane assembly and normalized epidermal phenotype. J Invest Dermatol 120, 923, 2003.
19. Howlett, A.R., and Bissell, M.J. The influence of tissue mi-croenvironment (stroma and extracellular matrix) on the development and function of mammary epithelium. Epithelial Cell Biol 2, 79, 1993.
20. Sun, C.C., Su Pang, J.H., Cheng, C.Y., Cheng, H.F., Lee, Y.S., Ku, W.C., Hsiao, C.H., Chen, J.K., and Yang, CM. Inter-leukin-1 receptor antagonist (IL-1RA) prevents apoptosis in ex vivo expansion of human limbal epithelial cells cultivated on human amniotic membrane. Stem Cells 24, 2130, 2006.
21. Hopkinson, A., Mcintosh, R.S., Layfield, R., Keyte, J., Dua, H.S., and Tighe, P.J. Optimised two-dimensional electrophoresis procedures for the protein characterisation of structural tissues. Proteomics 5, 1967, 2005.
22. Hopkinson, A., Mcintosh, R.S., Shanmuganathan, V., Tighe, P.J., and Dua, H.S. Proteomic analysis of amniotic membrane prepared for human transplantation: characterization of proteins and clinical implications. J Proteome Res 5, 2226, 2006.
23. Hopkinson, A., Mcintosh, R.S., Tighe, P.J., James, D.K., and Dua, H.S. Amniotic membrane for ocular surface reconstruction: donor variations and the effect of handling on TGF-beta content. Invest Ophthalmol Vis Sci 47, 4316, 2006.
24. Savage, C.R., Jr., Inagami, T., and Cohen, S. The primary structure of epidermal growth factor. J Biol Chem 247, 7612, 1972.
25. Tseng, S.C., Prabhasawat, P., Barton, K., Gray, T., and Meller, D. Amniotic membrane transplantation with or without limbal allografts for corneal surface reconstruction in patients with limbal stem cell deficiency. Arch Ophthalmol 116, 431, 1998.
26. Tsubota, K., and Shimazaki, J. Surgical treatment of children blinded by Stevens-Johnson syndrome. Am J Ophthalmol 128, 573, 1999.
27. Malak, T.M., and Bell, S.C. Structural characteristics of term human fetal membranes: a novel zone of extreme morphological alteration within the rupture site. Br J Obstet Gynaecol 101, 375, 1994.
28. Germain, L., Guignard, R., Rouabhia, M., and Auger, F.A. Early basement membrane formation following the grafting of cultured epidermal sheets detached with thermolysin or Dispase. Burns 21, 175, 1995.
29. Perreault, N., and Jean-Francois, B. Use of the dissociating enzyme thermolysin to generate viable human normal intestinal epithelial cell cultures. Exp Cell Res 224, 354, 1996.
30. Connon, C.J., Nakamura, T., Hopkinson, A., Quantock, A., Yagi, N., Doutch, J., and Meek, K.M. The biomechanics of amnion rupture: an x-ray diffraction study. PLoS ONE 2, e1147, 2007.
31. Halaburt, J.T., Uldbjerg, N., Helmig, R., and Ohlsson, K. The concentration of collagen and the collagenolytic activity in the amnion and the chorion. Eur J Obstet Gynecol Reprod Biol 31, 75, 1989.
32. Bou-Resli, M.N., Al-Zaid, N.S., and Ibrahim, M.E. Full-term and prematurely ruptured fetal membranes. An ultrastruc-tural study. Cell Tissue Res 220, 263, 1981.
33. Cohen, S. Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the newborn animal. J Biol Chem 237, 1555, 1962.
34. Urdea, M.S., Merryweather, J.P., Mullenbach, G.T., Coit, D., Heberlein, U., Valenzuela, P., and Barr, P.J. Chemical synthesis of a gene for human epidermal growth factor ur-ogastrone and its expression in yeast. Proc Natl Acad Sci USA 80, 7461, 1983.
35. Gray, A., Dull, T.J., and Ullrich, A. Nucleotide sequence of epidermal growth factor cDNA predicts a 128,000-molecular weight protein precursor. Nature 303, 722, 1983.
36. Bell, G.I., Fong, N.M., Stempien, M.M., Wormsted, M.A., Caput, D., Ku, L.L., Urdea, M.S., Rall, L.B., and Sanchez-Pescador, R. Human epidermal growth factor precursor: cDNA sequence, expression in vitro and gene organization. Nucleic Acids Res 14, 8427, 1986.
37. Sahin, U., Weskamp, G., Kelly, K., Zhou, H.M., Higa-shiyama, S., Peschon, J., Hartmann, D., Saftig, P., and Blobel, C.P. Distinct roles for ADAM10 and ADAM17 in ectodo-main shedding of six EGFR ligands. J Cell Biol 164, 769, 2004.
38. Chen, L., Hodges, R.R., Funaki, C., Zoukhri, D., Gaivin, R.J., Perez, D.M., and Dartt, D.A. Effects of alphalD-adrenergic receptors on shedding of biologically active EGF in freshly isolated lacrimal gland epithelial cells. Am J Physiol Cell Physiol 291, C946, 2006.
39. Shimizu, N., Behzadian, M.A., and Shimizu, Y. Genetics of cell surface receptors for bioactive polypeptides: binding of epidermal growth factor is associated with the presence of human chromosome 7 in human-mouse cell hybrids. Proc Natl Acad Sci USA 77, 3600, 1980.
40. Sunnarborg, S.W., Hinkle, C.L., Stevenson, M., Russell, W.E., Raska, C.S., Peschon, J.J., Castner, B.J., Gerhart, M.J., Paxton, R.J., Black, R.A., and Lee, D.C. Tumor necrosis factor-alpha converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability. J Biol Chem 277, 12838, 2002.
41. Beuerman, R.W., and Thompson, H.W. Molecular and cellular responses of the corneal epithelium to wound healing. Acta Ophthalmol Suppl 7, 202, 7, 1992.
42. Wilson, S.E., Chen, L., Mohan, R.R., Liang, Q., and Liu, J. Expression of HGF, KGF, EGF and receptor messenger RNAs following corneal epithelial wounding. Exp Eye Res 68, 377, 1999.
43. Nakamura, Y., Sotozono, C., and Kinoshita, S. The epidermal growth factor receptor (EGFR): role in corneal wound healing and homeostasis. Exp Eye Res 72, 511, 2001.
44. Kruse, F.E., and Tseng, S.C. Growth factors modulate clonal growth and differentiation of cultured rabbit limbal and corneal epithelium. Invest Ophthalmol Vis Sci 34, 1963, 1993.
45. Fawthrop, R.K., and Ockleford, CD. Cryofracture of human term amniochorion. Cell Tissue Res 277, 315, 1994.
46. Scott, S.M., Watterberg, K., Rogers, C., Hartenberger, C., Merker, L., and Gifford, K.L. Positive relationship of Cortisol concentrations and oral nutrition to epidermal growth factor concentrations in preterm infants. Biol Neonate 74, 259, 1998.
47. Walzer, C., Benathan, M., and Frenk, E. Thermolysin treatment: a new method for dermo-epidermal separation. J Invest Dermatol 92, 78, 1989.
48. Wiedenmann, B., Lawley, K., Grund, C., and Branton, D. Solubilization of proteins from bovine brain coated vesicles by protein perturbants and Triton X-100. J Cell Biol 101, 12, 1985.
49. Delaunay, J.L., Breton, M., Trugnan, G., and Maurice, M. Differential solubilization of inner plasma membrane leaflet components by Lubrol WX and Triton X-100. Biochim Biophys Acta 1778, 105, 2008.
50. Corton, M., Villuendas, G., Botella, J.I., San Millan, J.L., Escobar-Morreale, H.F., and Peral, B. Improved resolution of the human adipose tissue proteome at alkaline and wide range pH by the addition of hydroxyethyl disulfide. Proteomics 4, 438, 2004.
51. Massague, J., and Pandiella, A. Membrane-anchored growth factors. Annu Rev Biochem 62, 515, 1993.
52. Dong, J., Opresko, L.K., Chrisler, W., Orr, G., Quesenberry, R.D., Lauffenburger, D.A., and Wiley, H.S. The membrane-anchoring domain of epidermal growth factor receptor ligands dictates their ability to operate in juxtacrine mode. Mol Biol Cell 16, 2984, 2005.
53. Wong, S.T., Winchell, L.F., McCune, B.K., Earp, H.S., Teixido, J., Massague, J., Herman, B., and Lee, D.C. The TGF-alpha precursor expressed on the cell surface binds to the EGF receptor on adjacent cells, leading to signal transduction. Cell 56, 495, 1989.
54. Brachmann, R., Lindquist, P.B., Nagashima, M., Kohr, W., Lipari, T., Napier, M., and Derynck, R. Transmembrane TGF-alpha precursors activate EGF/TGF-alpha receptors. Cell 56, 691, 1989.
55. Goishi, K., Higashiyama, S., Klagsbrun, M., Nakano, N., Umata, T., Ishikawa, M., Mekada, E., and Taniguchi, N. Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity. Mol Biol Cell 6, 967, 1995.
56. Nakagawa, T., Higashiyama, S., Mitamura, T., Mekada, E., and Taniguchi, N. Amino-terminal processing of cell surface heparin-binding epidermal growth factor-like growth factor up-regulates its juxtacrine but not its paracrine growth factor activity. J Biol Chem 271, 30858, 1996.
57. Shortt, A.J., Seeker, G.A., Notara, M.D., Limb, G.A., Khaw, P.T., Tuft, S.J., and Daniels, J.T. Transplantation of ex vivo cultured limbal epithelial stem cells: a review of techniques and clinical results. Surv Ophthalmol 52, 483, 2007.